[1]吴苏名,王贺,陈基黎,等.应用OCTA检测羟氯喹对系统性红斑狼疮患者黄斑区视网膜微血管形态的影响[J].眼科新进展,2020,40(9):871-874.[doi:10.13389/j.cnki.rao.2020.0198]
　WU Suming,WANG He,CHEN Jili,et al.Application of OCTA in detecting the effects of hydroxychloroquine on the retinal microvasculature in patients with systemic lupus erythematosus[J].Recent Advances in Ophthalmology,2020,40(9):871-874.[doi:10.13389/j.cnki.rao.2020.0198]
点击复制

应用OCTA检测羟氯喹对系统性红斑狼疮患者黄斑区视网膜微血管形态的影响/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
40卷
期数:
2020年9期
页码:
871-874
栏目:
应用研究
出版日期:
2020-09-05

文章信息/Info

Title:
Application of OCTA in detecting the effects of hydroxychloroquine on the retinal microvasculature in patients with systemic lupus erythematosus
作者:
吴苏名; 王贺; 陈基黎; 郭建新
221006　江苏省徐州市，徐州医科大学附属医院眼科
Author(s):
WU Suming; WANG He; CHEN Jili; GUO Jianxin
Department of Ophthalmology,the Affiliated Hospital of Xuzhou Medical University,Xuzhou 221006,Jiangsu Province,China
关键词:
羟氯喹; 光学相干断层扫描血管成像; 视网膜毒性; 视野; 多焦视网膜电图
Keywords:
hydroxychloroquine;  optical coherence tomography angiography;  retinal toxicity;  visual field;  multifocal electroretinography
分类号:
R774
DOI:
10.13389/j.cnki.rao.2020.0198
文献标志码:
A
摘要:
目的　通过光学相干断层扫描血管成像（optical coherence tomography angiography,OCTA）检测羟氯喹（hydroxychloroquine,HCQ）对系统性红斑狼疮（systemic lupus erythematosus，SLE)患者黄斑区视网膜微血管形态的影响。方法　回顾性病例研究。将服用HCQ的患者60例60眼纳入研究，根据HCQ视网膜毒性的服药累积时间，将患者分为高危组（服药累积时间≥5 a）和低危组（服药累积时间<5 a），所有患者均进行光学相干断层扫描（optical coherence tomography,OCT）、OCTA、自动化视野检查（auto visual field,AVF）及多焦视网膜电图（multifocal electroretinography,mfERG）检查。结果　与低危组相比，高危组患者OCTA检查结果显示，视网膜浅表毛细血管丛和深部毛细血管丛血管密度均降低（均为P<0.05），而中心凹无血管区扩大（P<0.05）。 HCQ累积剂量和累积时间均与FAZ参数呈正相关（均为P<0.05）。在视野测试中，与低危组相比，高危组的平均偏差增加。在mfERG检查中，高危组的中心凹及旁中心凹振幅密度较低危组均有下降（均为P<0.05）。结论　OCTA通过评估视网膜微血管变化有助于检测HCQ引起的视网膜毒性。
Abstract:
Objective　To detect the effects of hydroxychloroquine (HCQ) on the retinal microvasculature in patients with systemic lupus erythematosus (SLE) by optical coherence tomography angiography (OCTA).Methods　Retrospective case study. Sixty eyes of 60 patients taking HCQ were enrolled in the study. According to the cumulative time of taking HCQ, patients were divided into high-risk group (≥5 years) and low-risk group (<5 years). All patients were tested by optical coherence tomography (OCT)，OCTA, auto visual field and multifocal electroretinography (mfERG).Results　Compared with the low-risk group, OCTA showed that the vascular density of superficial capillary plexus (SCP) and deep capillary plexus (DCP) were significantly lower in the high-risk group (both P<0.05), and the fovea avascular zone (FAZ) was wider (P<0.05). The cumulative dose and duration of HCQ were both significantly positively correlated with parameters of FAZ (both P<0.05). In the visual field test, the mean deviation (MD) of the high-risk group was significantly increased. Compared with the low-risk group, the amplitude densities in foveal and parafoveal were significantly decreased in the high-risk group by mfERG (both P<0.05).Conclusion　OCTA can be helpful in detecting retinal toxicity induced by HCQ via assessing retinal microvascular changes.

参考文献/References:

［1］YUSUF I H,SHARMA S,LUQMANI R,DOWNES S M.Hydroxychloroquine retinopathy［J］.Eye,2017,31(6):828-845.
［2］　李雅楠,李晶晶.硫酸羟氯喹治疗风湿病的临床效果及安全性［J］.养生保健指南,2019,(32):27.
LI Y N,LI J J.Clinical effect and safety of hydroxychloroquine sulfate in the treatment of rheumatism ［J］.Health Guide,2019,(32):27
［3］　PASAOGLU I.Macular toxicity after short-term hydroxychloroquine therapy［J］.Indian J Ophthalmol,2019,67(2):289-292.
［4］　PROANO C,KIMBALL G P.Hydroxychloroquine retinal toxicity［J］.N Engl J Med,2019,380(17):e27.
［5］　PHAM B H，MARMOR M F.Sequential changes in hydroxychloroquine retinopathy up to 20 years after stopping the drug:implications for mild versus severe toxicity［J］.Retina,2019,39(3):492-501.
［6］　MARMOR M F,KELLNER U,LAI T Y Y,MELLES R B,MIELER W F,AMERICAN ACADEMY OF OPHTHALMOLOGY.Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision）［J］.Ohthalmology,2016,123(6):1386-1394.
［7］　AHN S J,JOUNG J,LEE B R.Evaluation of hydroxychloroquine retinopathy using ultra-widefield fundus autofluorescence:peripheral findings in the retinopathy［J］.Am J Ophthalmol,2020,209:35-44.
［8］　SAUERR L,CALVO C M,VITALE A S,HENRIE N,MILLIKEN C M,BERNSTEIN P S.Imaging of hydroxychloroquine toxicity with fluorescence lifetime imaging ophthalmoscopy［J］.Ophthalmol Retina,2019,3(10):814-825.
［9］　ZAIDI F H,RENNIE C A,DRINKWATER A K,SAHU D,AKYOL E,LOTERY A J.How to set up a hydroxychloroquine retinopathy screening service［J］.Eye,2019,33(11):1679-1682.
［10］　PHAM B H,MARMOR M F.Sequential changes in hydroxychloroquine retinopathy up to 20 years after stopping the drug:implications for mild versus severe toxicity［J］.Retina,2019,39(3):492-501.
［11］　ALLAHDINA A M,CHEN K G,ALVAREZ J A,WONG W T,CHEW E Y,CUKRAS C A.Longitudinal changes in eyes with hydroxychloroquine retinal toxicity［J］.Retina,2019,39(3):473-484.
［12］　MELLES R B,MARMORR M F.Pericentral retinopathy and racial differences in hydroxychloroquine toxicity［J］.Ophthalmology,2015,122(1):110-116.
［13］　CORRADETTI G,VIOLANTI S,AU A,SARRAF D.Wide field retinal imaging and the detection of drug associated retinal toxicity［J］.Int J Retina Vitreous,2019,5(Suppl 1):26.
［14］　HOOD D C,BACH M,BRIGELLl M,KEATING D,KONDO M,LYONS J S.ISCEV standard for clinical multifocal electroretinography (mfERG) ［J］.Doc Ophthalmol,2011,124(1):1-13.
［15］　胡赛静,毛崇溶.应用OCT观察羟氯喹对视网膜的早期影响［J］.中华眼视光学与视觉科学杂志,2015,17(3):181-183.
HU S J,MAO C R.Early effect of hydroxychloroquine on retina by OCT ［J］.Chin J Optom Vis Sci,2015,17 (3):181-183.
［16］　MARTN-IGLESIAS D,ARTARAZ J,FONOLLOSA A,UGARTE A,ARTEAGABEITIA A,RUIZ-IRASTORZA G.Evolution of retinal changes measured by optical coherence tomography in the assessment of hydroxychloroquine ocular safety in patients with systemic lupus erythematosus［J］.Lupus,2019,28(4):555-559.
［17］　TRENKIC BOINOVIC M S,STANKOVIC BABIC G,PETROVIC M,KARADIC J,S ARENAC VULOVIC T,TRENKIC M.Role of optical coherence tomography in the early detection of macular thinning in rheumatoid arthritis patients with chloroquine retinopathy［J］.J Res Med Sci,2019,24:55.
［18］　MARTN-IGLESIAS D,ARTARAZ J,FONOLLOSA A,UGARTE A,ARTEAGABEITIA A,RUIZ-IRASTORZA.Evolution of retinal changes measured by optical coherence tomography in the assessment of hydroxychloroquine ocular safety in patients with systemic lupus erythematosus［J］.Lupus,2019,28(4):555-559.
［19］　XU C H,ZHU L,CHAN T,LU X X,SHEN W Y,MADIGAN M C.Chloroquine and hydroxychloroquine are novel inhibitors of human organic anion transporting polypeptide 1A2［J］.J Pharm Sci,2016,105(2):884-890.
［20］　KORTHAGEN N M,BASTIAANS J,VAN MEURS J C,VAN BILSEN K,VAN HAGEN P M,DIK W A.Chloroquine and hydroxychloroquine increase retinal pigment epithelial layer permeability［J］.J Biochem Mol Toxicol,2015,29(7):299-304.
［21］　WOLFE F,MARMOR M F.Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus［J］.Arthritis Care Res (Hoboken),2010,62(6):775-784.

相似文献/References:

[1]董秀芬,钟华.Angio-OCT在眼科疾病临床应用中研究进展[J].眼科新进展,2016,36(7):697.[doi:10.13389/j.cnki.rao.2016.0185]
　DONG Xiu-Fen,ZHONG Hua.Application of Angio-OCT in ophthalmic diseases[J].Recent Advances in Ophthalmology,2016,36(9):697.[doi:10.13389/j.cnki.rao.2016.0185]
[2]刘青,艾明.光学相干断层扫描血管成像（OCTA）和荧光素血管造影（FFA）对比观察增生型糖尿病视网膜病变（PDR）[J].眼科新进展,2017,37(1):052.[doi:10.13389/j.cnki.rao.2017.0014]
　LIU Qing,AI Ming.Characteristics of proliferative diabetic retinopathy observed by optical coherence tomography angiography and fundus fluorescein angiography[J].Recent Advances in Ophthalmology,2017,37(9):052.[doi:10.13389/j.cnki.rao.2017.0014]
[3]仲妍,车慧欣.光学相干断层扫描血管成像（OCTA）在原发性青光眼患者中的检测价值[J].眼科新进展,2018,38(4):352.[doi:10.13389/j.cnki.rao.2018.0082]
　ZHONG Yan,CHE Hui-Xin.Detective values of optical coherence tomography angiographyfor primary glaucoma[J].Recent Advances in Ophthalmology,2018,38(9):352.[doi:10.13389/j.cnki.rao.2018.0082]
[4]冷云霞,张柳,张蒙,等.早产儿视网膜病变黄斑中心视网膜微血管形态特征：基于光学相干断层扫描血管成像（OCTA）的观察[J].眼科新进展,2018,38(4):357.[doi:10.13389/j.cnki.rao.2018.0083]
　LENG Yun-Xia,ZHANG Liu,ZHANG Meng,et al.Observation of central macular retinal microvascular network morphology of retinopathy of prematurity by optical coherence tomography angiography[J].Recent Advances in Ophthalmology,2018,38(9):357.[doi:10.13389/j.cnki.rao.2018.0083]
[5]焦亚,付碧波,叶波,等.视网膜脱离复位术后黄斑区血流密度：基于光学相干断层扫描血管成像（OCTA）的观察[J].眼科新进展,2018,38(4):373.[doi:10.13389/j.cnki.rao.2018.0087]
　JIAO Ya,FU Bi-Bo,YE Bo,et al.Clinical observation of optical coherence tomography angiography in the macular vascular density after repair of retinal detachment[J].Recent Advances in Ophthalmology,2018,38(9):373.[doi:10.13389/j.cnki.rao.2018.0087]
[6]郑丹,庞东渤.应用光学相干断层扫描血管成像（OCTA）评估糖尿病患者早期黄斑区视网膜微循环[J].眼科新进展,2018,38(6):548.[doi:10.13389/j.cnki.rao.2018.0128]
　ZHENG Dan,PANG Dong-Bo.Evaluation of early macular retinal microcirculation in diabetic patients using optical coherence tomography angiography[J].Recent Advances in Ophthalmology,2018,38(9):548.[doi:10.13389/j.cnki.rao.2018.0128]
[7]袁晴,闵幼兰,邵毅.光学相干断层扫描血管成像技术在神经眼科疾病中的应用[J].眼科新进展,2018,38(8):794.[doi:10.13389/j.cnki.rao.2018.0188]
　YUAN Qing,MIN You-Lan,SHAO Yi.Application of optical coherence tomography angiography in neuro-ophthalmological diseases[J].Recent Advances in Ophthalmology,2018,38(9):794.[doi:10.13389/j.cnki.rao.2018.0188]
[8]张晓培,曹国凡,蒋沁.光学相干断层扫描血管成像（OCTA）对早期原发性开角型青光眼的诊断能力[J].眼科新进展,2018,38(9):847.[doi:10.13389/j.cnki.rao.2018.0200]
　ZHANG Xiao-Pei,CAO Guo-Fan,JIANG Qin.Discriminant function of optical coherence tomography angiography to determine early primary open angle glaucoma[J].Recent Advances in Ophthalmology,2018,38(9):847.[doi:10.13389/j.cnki.rao.2018.0200]
[9]孙姣,王佳琳,王艳玲,等.眼部血管密度测量及其临床意义研究进展[J].眼科新进展,2018,38(11):1089.[doi:10.13389/j.cnki.rao.2018.0257]
　SUN Jiao,WANG Jia-Lin,WANG Yan-Ling,et al.Research progress of vessel density in ocular diseases[J].Recent Advances in Ophthalmology,2018,38(9):1089.[doi:10.13389/j.cnki.rao.2018.0257]
[10]吕湘云,艾明.光学相干断层扫描血管成像（OCTA）在黄斑疾病中的应用进展[J].眼科新进展,2019,39(1):094.[doi:10.13389/j.cnki.rao.2019.0022]
　LV Xiang-Yun,AI Ming.Research advance in clinical application of optical coherence tomography angiography in macular diseases[J].Recent Advances in Ophthalmology,2019,39(9):094.[doi:10.13389/j.cnki.rao.2019.0022]

备注/Memo

备注/Memo:
N/A
更新日期/Last Update: 2020-09-05